Chronic administration of morphine is associated with a decrease in surface AMPA GluR1 receptor subunit in dopamine D1 receptor expressing neurons in the shell and non-D1 receptor expressing neurons in the core of the rat nucleus accumbens

Experimental Neurology

Volumn 210, Issue 2, 2008, Pages 750-761

  Glass, Michael J ^a   Lane, Diane A ^a   Colago, Eric E O ^a   Chan, June ^a   Schlussman, Stefan D ^b   Zhou, Yan ^b   Kreek, Mary Jeanne ^b   Pickel, Virginia M ^a  

^a Department of Obstetrics Gynecology   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Addiction; Dopamine; Dopamine D1R receptor; Glutamate; Nucleus accumbens core; Nucleus accumbens shell; Synaptic plasticity

Indexed keywords

AMPA RECEPTOR; DOPAMINE 1 RECEPTOR; GLUTAMATE RECEPTOR; MORPHINE; PEROXIDASE; RECEPTOR SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENDRITE; IMMUNOGOLD ELECTRON MICROSCOPY; MALE; MORPHINE ADDICTION; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR, ANIMAL; DENDRITES; DRUG ADMINISTRATION SCHEDULE; MALE; MICROSCOPY, IMMUNOELECTRON; MORPHINE; NARCOTICS; NEURONS; NUCLEUS ACCUMBENS; PROTEIN TRANSPORT; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D1;

EID: 41349121976     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.01.012     Document Type: Article

References (57)

1. Brebner K., Wong T.P., Liu L., Liu Y., Campsall P., Gray S., Phelps L., Phillips A.G., and Wang Y.T. Nucleus accumbens long-term depression and the expression of behavioral sensitization. Science 310 (2005) 1340-1343
2. Brog J.S., Salyapongse A., Deutch A.Y., and Zahm D.S. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. J. Comp. Neurol. 338 (1993) 255-278
3. Buckingham J.C., and Cooper T. Differences in hypothalamo-pituitary-adrenal activity in rats after acute and prolonged treatment with morphine. Neuroendocrinology 38 (1984) 411-417
4. Bussey T.J., Everitt B.J., and Robbins T.W. Dissociable effects of cingulate and medial frontal cortex lesions on stimulus-reward learning using a novel Pavlovian autoshaping procedure for the rat: implications for the neurobiology of emotion. Behav. Neurosci. 111 (1997) 908-919
5. Buzas B., Rosenberger J., and Cox B.M. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport 7 (1996) 1505-1508
6. Cadoni C., and Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neurosci. 90 (1999) 447-455
7. Chan J., Aoki C., and Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J. Neurosci. Methods 33 (1990) 113-127
8. Chartoff E.H., Mague S.D., Barhight M.F., Smith A.M., and Carlezon W.A. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J. Neurosci. 26 (2006) 6450-6457
9. Chefer V.I., Kieffer B.L., and Shippenberg T.S. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. Eur. J. Neurosci. 18 (2003) 1915-1922
10. Cheng J.J., de Bruin J.P., and Feenstra M.G. Dopamine efflux in nucleus accumbens shell and core in response to appetitive classical conditioning. Eur. J. Neurosci. 18 (2003) 1306-1314
11. Cull-Candy S., Kelly L., and Farrant M. Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr. Opin. Neurobiol. 16 (2006) 288-297
12. Deutch A.Y., and Cameron D. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neurosci. 46 (1992) 49-56
13. Di Ciano P., and Everitt B.J. Dissociable effect of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behaviour. Neuropsychopharmacology 25 (2001) 341-360
14. French S.J., and Totterdell S. Quantification of morphological differences in boutons from different afferent populations to the nucleus accumbens. Brain Res. 1007 (2004) 167-177
15. Gerfen C.R., Herkenham M., and Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7 (1987) 3915-3934
16. Glass M.J., Kruzich P.J., Colago E.E., Kreek M.J., and Pickel V.M. Increased AMPA GluR1 receptor subunit labeling on the plasma membrane of dendrites in the basolateral amygdala of rats self-administering morphine. Synapse 58 (2005) 1-12
17. Glass M.J., Kruzich P.J., Kreek M., and Pickel V.M. Decreased plasma membrane targeting of NMDA-NR1 receptor subunit in dendrites of medial nucleus tractus solitarius neurons in rats self-administering morphine. Synapse 53 (2004) 191-201
18. Hara Y., and Pickel V.M. Overlapping intracellular and differential synaptic distributions of dopamine D1 and glutamate N-methyl-d-aspartate receptors in rat nucleus accumbens. J. Comp. Neurol. 492 (2005) 442-455
19. Hara Y., Yakovleva T., Bakalkin G., and Pickel V.M. Dopamine D1 receptors have subcellular distributions conducive to interactions with prodynorphin in the rat nucleus accumbens shell. Synapse 60 (2006) 1-19
20. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., and Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neurosci. 41 (1991) 89-125
21. Hernandez P.J., Andrzejewski M.E., Sadeghian K., Panksepp J.B., and Kelley A.E. AMPA/kainate, NMDA, and dopamine D1 receptor function in the nucleus accumbens core: a context-limited role in the encoding and consolidation of instrumental memory. Learn. Memory 12 (2005) 285-295
22. Hirose N., Murakawa K., Takada K., Oi Y., Suzuki T., Nagase H., Cools A.R., and Koshikawa N. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neurosci. 135 (2005) 213-225
23. Ignar D.M., and Kuhn C.M. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. J. Pharmacol. Exp. Therap. 255 (1990) 1287-1295
24. Jarvie K.R., and Caron M.G. Heterogeneity of dopamine receptors. Adv. Neurol. 60 (1993) 325-333
25. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162 (2005) 1403-1413
26. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci. Biobehav. Rev. 27 (2004) 765-776
27. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22 (2002) 3306-3311
28. Kelz M.B., Chen J., Carlezon W.A., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., and Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401 (1999) 272-276
29. Koob G.F., and Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry 164 (2007) 1149-1159
30. Layer R.T., Uretsky N.J., and Wallace L.J. Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res. 617 (1993)
31. Maher C.E., Martin T.J., and Childers S.R. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration. Life Sci. 77 (2005) 1140-1154
32. Malenka R. Synaptic plasticity and AMPA receptor trafficking. Ann. N. Y. Acad. Sci. 1003 (2003) 1-11
33. Mangiavacchi S., and Wolf M.E. D1 dopamine receptor stimulation increases the rate of AMPA receptor insertion onto the surface of cultured nucleus accumbens neurons through a pathway dependent on protein kinase A. J. Neurochem. 88 (2004) 1261-1271
34. Mansour A., Fox C.A., Thompson R.C., Akil H., and Watson S.J. mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res. 643 (1994) 245-265
35. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
36. McFarland K., Davidge S.B., Lapish C.C., and Kalivas P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 24 (2004) 1551-1560
37. Meredith G.E. The synaptic framework for chemical signaling in nucleus accumbens. Ann. N. Y. Acad. Sci. 877 (1999) 140-156
38. Mogenson G.J. Limbic-motor integration. Prog. Physiol. Psychol. 12 (1987) 117-170
39. Moriwaki A., Wang J.B., Svingos A., van Bockstaele E., Cheng P., Pickel V., and Uhl G.R. mu Opiate receptor immunoreactivity in rat central nervous system. Neurochem. Res. 21 (1996) 1315-1331
40. Noble F., and Cox B.M. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol. 117 (1996) 161-169
41. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, New York
42. Peters A., Palay S.L., and Webster H. The Fine Structure of the Nervous System (1991), Oxford University Press Oxford University Press
43. Pontieri F.E., Tanda G., and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. PNAS 92 (1995) 12304-12308
44. Rossetti Z.L., Hmaidan Y., and Gessa G.L. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221 (1992) 227-234
45. Schoffelmeer A.N., De Vries T.J., Vanderschuren L.J., Tjon G.H., Nestby P., Wardeh G., and Mulder A.H. Glucocorticoid receptor activation potentiates the morphine-induced adaptive increase in dopamine D-1 receptor efficacy in gamma-aminobutyric acid neurons of rat striatum/nucleus accumbens. J. Pharmacol. Exper. Therap. 274 (1995) 1154-1160
46. Self D.W. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacol. 47 Suppl 1 (2004) 242-255
47. Self D.W., McClenahan A.W., Beitner-Johnson D., Terwilliger R.Z., and Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21 (1995) 312-318
48. Shippenberg T.S., Bals-Kubik R., and Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exper. Therap. 265 (1993) 53-59
49. Sokolowski J.D., Conlan A.N., and Salamone J.D. A microdialysis study of nucleus accumbens core and shell dopamine during operant responding in the rat. Neurosci. 86 (1998) 1001-1009
50. Svingos A.L., Moriwaki A., Wang J.B., Uhl G.H., and Pickel V.M. Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu(5)-enkephalin. J. Neurosci. 16 (1996) 4162-4173
51. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 (1997) 2048-2050
52. Volkow N.D., and Wise R.A. How can drug addiction help us understand obesity?. Nat. Neurosci. 8 (2005) 555-560
53. Wang J.Q., Arora A., Yang L., Parelkar N.K., Zhang G., Liu X., Choe E.S., and Mao L. Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity. Mol. Neurobiol. 32 (2005) 237-249
54. Zahm D.S. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci. Biobehav. Rev. 24 (2000) 85-105
55. Zhou Y., Bendor J., Hofmann L., Randesi M., Ho A., and Kreek M. Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J. Endocrinol 191 (2006) 137-145
56. Zhou Y., Spangler R., Maggos C.E., Wang X.M., Han J.S., Ho A., and Kreek M. Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress. J. Endocrinol. 163 (1999) 261-267
57. Zigmond R.E., Schwarzschild M.A., and Rittenhouse A.R. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci. 12 (1989) 415-461